College of Pharmacy
In this section
Podcast Archive
HelixTalk Episode #69 - The pharmacist must see you now - A new rule requiring pharmacist counseling in Illinois
Date posted: November 7, 2017, 6:00 am
In this episode, we interview Dylan Moe, PharmD, our very own alumnus, regarding the new Illinois rule requiring patient counseling for all new prescriptions and inquire how the new rule has impacted his pharmacy, work environment, and his opinions on the implementation of the rule.
HelixTalk Episode #68 - Hooked on a feeling: how to discuss benzodiazepine tapers with your patients
Date posted: October 17, 2017, 6:00 am
In this episode, we will discuss the current state of benzodiazepine use, expected trends in prescribing, and risks associated with use. Lastly, we will discuss techniques for ensuring that a benzodiazepine taper is performed in a safe manner with lowest risk of harm.
HelixTalk Episode #67 - Diabetes: does it cost a “heart” and a leg?
Date posted: September 26, 2017, 6:00 am
In this episode, we discuss new evidence for cardiovascular outcomes in diabetics based on the LEADER trial (liraglutide) and CANVAS trials (canagliflozin). We also discuss the new FDA warning for canagliflozin regarding amputation risk.
HelixTalk Episode #66 - What’s new in the diabetes world? Tapas style!
Date posted: September 5, 2017, 6:00 am
In this episode, we discuss updates in diabetes management that includes nuances from the ADA’s Standards of Care 2017. We also review some newer pharmacologic agents, a fixed dose GLP-1 agonist and basal insulin combinations.
HelixTalk Episode #65 - Advanced hypertension ninja skills with some of the oldest BP meds
Date posted: August 15, 2017, 6:00 am
In this episode, we discuss three "older" antihypertensives that are not preferred first-line therapies: clonidine, methyldopa, and minoxidil. We outline why these agents are not first-line therapies and review their pharmacology and adverse effect profiles.
HelixTalk Episode #64 - Should I stay or should ergot?
Date posted: July 25, 2017, 6:00 am
In this episode, we discuss the history of ergot products for treatment of migraines. We compare their safety and efficacy to newer agents such as the triptans and assess their resultant place in therapy.
HelixTalk Episode #63 - More is not always better - Story of Serotonin Syndrome
Date posted: July 4, 2017, 6:00 am
In this episode, we discuss several aspects of serotonin syndrome including the typical clinical presentation, its etiology and common drug-induced combinations, and how to appropriately manage the syndrome.
HelixTalk Episode #62 - Devices not drugs: stroke risk reduction in atrial fibrillation
Date posted: June 13, 2017, 6:00 am
In this episode, we discuss the pathophysiology of embolic stroke in patients with atrial fibrillation and review the use of left atrial occlusion devices, such as the WATCHMAN device, to reduce the risk of stroke in patients with atrial fibrillation without the use of anticoagulants like warfarin.
HelixTalk Episode #61 - Correcting the course: careful opioid prescribing
Date posted: May 23, 2017, 6:00 am
In this episode, we review the 12 recommendations from the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. These recommendations are intended to help curb the opioid epidemic and provide guidance to healthcare providers regarding safer use of opioid therapy.
HelixTalk Episode #60 - How to get your voice heard? - Pearls of Professional Advocacy
Date posted: May 2, 2017, 6:00 am
In this episode, we discuss the concept of professional advocacy, with a particular focus on how to advocate for the profession of pharmacy and what tools and organizations are available to assist in being an advocate.